BTW, the LGND spinoff VKTX has been on a tear lately. I have a modest speculative position acquired a few months back because of their thyroid receptor beta (TRß) agonist.
But VKTX is a much lower-grade company and management than LGND itself.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.